跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,042 条关于
“BTC”
全部
2,042
临床试验
1,319
药物
334
机构
37
资讯
352
去年
Ziihera (Zanidatamab-hrii) Approved for HER2-Positive Biliary Tract Cancer
去年
FDA Grants Accelerated Approval to Ziihera for HER2-Positive Biliary Tract Cancer
去年
FDA Grants Accelerated Approval to Zanidatamab for HER2+ Biliary Tract Cancer
去年
Bicycle Toxin Conjugates Emerge as Novel Cancer Drug Class with Promising Clinical Results
去年
Targeted Therapies Transform Biliary Tract Cancer Treatment as HER2-Directed Agents Gain FDA Approval
去年
Ziihera (Zanidatamab-hrii) Receives NCCN Recommendation for Biliary Tract Cancers
去年
FDA Approves Ziihera (zanidatamab-hrii) for HER2-Positive Biliary Tract Cancer
去年
FDA Grants Accelerated Approval to Zanidatamab for HER2-Positive Biliary Tract Cancer
2年前
Jazz Pharmaceuticals Completes FDA Submission for Zanidatamab in HER2-Positive Biliary Tract Cancer
去年
FDA Approves Jazz Pharmaceuticals' Ziihera (zanidatamab-hrii) for HER2-Positive Biliary Tract Cancer
第 1 页,共 36 页
上一页
下一页